Publication of a newspaper advertisement for the unaudited Financial Results for the Quarter ended on June 30, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bharat Parenterals Ltd (BSE Scrip Code: 541096) has submitted copies of a newspaper advertisement to BSE confirming the publication of its unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1FY26). The advertisement was published on July 30, 2025 in Business Standard (English) and Vadodara Samachar (regional language). The filing has been made in compliance with Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The actual financial numbers (revenue, profit, EPS, etc.) are not part of this filing — they are contained in the separate detailed results filed under Regulation 33, which would have been approved by the Board and Audit Committee prior to this publication.
This is a routine regulatory compliance filing confirming that Q1FY26 results were duly published in newspapers, as SEBI requires. It carries no direct material impact on the stock price, but signals that the company's quarterly results are officially out and available for public review. Investors should look at the separate detailed financial results filing for actual performance data.